Eli Lilly and Company
Utility Patent Applications
Last updated:
List of all Eli Lilly and Company patents 234 in total
| Status | Patent |
|---|---|
Application | Utility: GIP/GLP1 CO-AGONIST COMPOUNDS Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: DOSE DETECTION AND DRUG IDENTIFICATION FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: (E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL-5-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-7-YL)AMINO)PIPERIDINE-1-- CARBOXYLATE FOR INHIBITING CDK7 Filling date: 18 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: SELECTIVE ESTROGEN RECEPTOR DEGRADERS Filling date: 18 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: ACCELERATED TESTING METHOD OF SILICONE DRAINAGE IN SYRINGES Filling date: 18 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T Filling date: 18 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: GIP/GLP1 AGONIST COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: COMBINATION THERAPY OF BACE-1 INHIBITOR AND ANTI-N3PGLU ABETA ANTIBODY Filling date: 18 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: ACYLATED INSULIN COMPOUND Filling date: 18 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: PYRROLIDINONE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: COMBINATION OF RAMUCIRUMAB AND MERESTINIB FOR USE IN TREATMENT OF COLORECTAL CANCER Filling date: 18 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL Filling date: 18 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: DOPAMINE D1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS Filling date: 18 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM Filling date: 18 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: GROWTH DIFFERENTIATION FACTOR 15 AGONIST COMPOUNDS AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: Methods for Producing Fabs and IgG Bispecific Antibodies Filling date: 18 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: MUTANT IDH1 INHIBITORS Filling date: 18 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA Filling date: 18 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ANTI-RANKL ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: AMINO PYRIMIDINE SSAO INHIBITORS Filling date: 18 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: AMINO PYRIMIDINE COMPOUNDS USEFUL AS SSAO INHIBITORS Filling date: 18 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: PD-1 AGONIST ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: COMBINATION THERAPY WITH MERESTINIB AND ANTI-PD-L1 OR ANTI-PD-1 INHIBITORS FOR USE IN THE TREATMENT OF CANCER Filling date: 18 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: ANTI-TRKA ANTIBODY Filling date: 18 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH MECHANICAL LOCKING SYSTEM Filling date: 18 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: RAPID-ACTING INSULIN COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: Combination Therapy Filling date: 18 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: TARGETED TREATMENT OF MATURE T-CELL LYMPHOMA Filling date: 18 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: IL-21 ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 1 Aug 2019 |
Showing 200 to 234 of 234 patents.